Literature DB >> 3741723

In vivo cation transport during short-term and long-term digoxin therapy.

N A Boon, S E Pugh, K F Hallis, J K Aronson, D G Grahame-Smith.   

Abstract

We have studied the effects of digoxin on cation transport in vivo by measuring the changes in plasma and red cell rubidium concentrations following an oral load of rubidium chloride. In eight patients who had been taking digoxin for 7 to 10 days (mean plasma digoxin concentration 1.3 ng ml-1) the rise in plasma rubidium concentrations was enhanced and the rise in red cell rubidium concentrations was attenuated following the oral load of rubidium chloride, by comparison with the changes in well-matched controls. In contrast, the disposition of rubidium was not altered in 12 patients who had been taking digoxin for more than 3 months (mean plasma digoxin concentration 1.1 ng ml-1). These results suggest that the inhibitory effects of digoxin on cation transport are detectable in vivo during short-term therapy, but not during long-term therapy, and confirm our previous in vitro findings.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3741723      PMCID: PMC1401086          DOI: 10.1111/j.1365-2125.1986.tb02875.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  The sodium-potassium adenosine triphosphatase: pharmacological, physiological and biochemical aspects.

Authors:  A Schwartz; G E Lindenmayer; J C Allen
Journal:  Pharmacol Rev       Date:  1975-03       Impact factor: 25.468

Review 2.  Mechanism of action of therapeutic levels of cardiac glycosides.

Authors:  D Noble
Journal:  Cardiovasc Res       Date:  1980-09       Impact factor: 10.787

3.  A method for the study of cation transport in vivo: effects of digoxin administration and of chronic renal failure on the disposition of an oral load of rubidium chloride.

Authors:  N A Boon; J K Aronson; K F Hallis; N J White; A E Raine; D G Grahame-Smith
Journal:  Clin Sci (Lond)       Date:  1984-05       Impact factor: 6.124

4.  The early and late effects of digoxin treatment on the sodium transport, sodium content and Na+K+- ATPase or erythrocytes.

Authors:  M Cumberbatch; K Zareian; C Davidson; D B Morgan; R Swaminathan
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

Review 5.  The natriuretic hormone: recent developments.

Authors:  H E De Wardener; E M Clarkson
Journal:  Clin Sci (Lond)       Date:  1982-11       Impact factor: 6.124

6.  Sodium transport on polymorphonuclear leucocytes: effect of isolation by the Ficoll/Triosil method.

Authors:  L Poston; R B Jones; P J Hilton
Journal:  Clin Sci (Lond)       Date:  1982-05       Impact factor: 6.124

7.  Changes in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients receiving digoxin during the early phases of treatment of cardiac failure in regular rhythm and of atrial fibrillation.

Authors:  A R Ford; J K Aronson; D G Grahame-Smith; J G Carver
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

8.  The acute changes seen in cardiac glycoside receptor sites, 86rubidium uptake and intracellular sodium concentrations in the erythrocytes of patients during the early phases of digoxin therapy are not found during chronic therapy: pharmacological and therapeutic implications for chronic digoxin therapy.

Authors:  A R Ford; J K Aronson; D G Grahame-Smith; J G Carver
Journal:  Br J Clin Pharmacol       Date:  1979-08       Impact factor: 4.335

9.  A new test showing abnormal net Na+ and K+ fluxes in erythrocytes of essential hypertensive patients.

Authors:  R P Garay; P Meyer
Journal:  Lancet       Date:  1979-02-17       Impact factor: 79.321

10.  A sensitive high-temperature electrothermal atomic absorption analysis for Rb+ in erythrocytes and plasma of normal and hypertensive persons.

Authors:  K F Hallis; N A Boon; C M Perkins; J K Aronson; D G Grahame-Smith
Journal:  Clin Chem       Date:  1985-02       Impact factor: 8.327

View more
  1 in total

1.  Reversible inhibition of leucocyte sodium pumps by a circulating serum factor in essential hypertension.

Authors:  P Finotti
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-13
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.